Cytokinetics CYTK Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Collaboration Revenues | $9.74M+131% | $8.69M+153% | $7.86M+212% | $6.39M+108% | $4.22M+10.3% | |
| License And Milestone Revenues | $91.28M+509% | $79.35M+429% | $79.35M+8,969% | $79.35M+4,434% | $15M+471% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Cytokinetics break its business down?
- Cytokinetics (CYTK) reports revenue by product across 3 parts — Collaboration Revenues, License And Milestone Revenues and Net Product Revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does Cytokinetics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Cytokinetics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
